World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
157
Citations
122685
World Ranking
873
National Ranking
496

Overview

Jaffer A. Ajani is affiliated with The University of Texas MD Anderson Cancer Center in the United States. Their research primarily focuses on medicine, with substantial contributions in pulmonary and respiratory medicine, oncology, surgery, gastroenterology, and molecular biology.

Their work covers multiple key topics in cancer research and treatment, including:

  • Gastric Cancer Management and Outcomes
  • Esophageal Cancer Research and Treatment
  • Cancer Immunotherapy and Biomarkers
  • Gastrointestinal Tumor Research and Treatment
  • Pancreatic and Hepatic Oncology Research
  • Colorectal Cancer Treatments and Studies
  • Metastasis and carcinoma case studies

Jaffer A. Ajani has collaborated with various researchers, frequently co-authoring work with:

  • Shumei Song
  • Brian D. Badgwell
  • Melissa Pool Pizzi
  • Kohei Shitara
  • Naruhiko Ikoma

The scientist's recent publications include:

  • Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology, 2022, Journal of the National Comprehensive Cancer Network
  • First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial, 2021, The Lancet
  • Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer, 2021, New England Journal of Medicine

Jaffer A. Ajani frequently publishes in well-known journals, with a significant number of publications in:

  • Journal of Clinical Oncology
  • Cancer Research
  • Annals of Oncology
  • Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature
  • Annals of Surgical Oncology

Best Publications

  • Comprehensive molecular characterization of gastric adenocarcinoma

    Adam J. Bass;Vesteinn Thorsson;Ilya Shmulevich;Sheila M. Reynolds

  • Chemoradiotherapy after Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal Junction

    John S. Macdonald;Stephen R. Smalley;Jacqueline Benedetti;Scott A. Hundahl

  • The Immune Landscape of Cancer

    Vésteinn Thorsson;David L Gibbs;Scott D Brown;Denise Wolf

  • Oncogenic Signaling Pathways in The Cancer Genome Atlas

    Francisco Sanchez-Vega;Marco Mina;Joshua Armenia;Walid K. Chatila

  • Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial

    Hansjochen Wilke;Kei Muro;Eric Van Cutsem;Sang Cheul Oh

  • Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

    Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf

  • Phase III Study of Docetaxel and Cisplatin Plus Fluorouracil Compared With Cisplatin and Fluorouracil As First-Line Therapy for Advanced Gastric Cancer: A Report of the V325 Study Group

    Eric Van Cutsem;Vladimir M. Moiseyenko;Sergei Tjulandin;Alejandro Majlis

  • Comprehensive Characterization of Cancer Driver Genes and Mutations.

    Matthew H Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial.

    Yelena Y Janjigian;Yelena Y Janjigian;Kohei Shitara;Markus Moehler;Marcelo Garrido

  • Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer

    David P. Kelsen;Robert Ginsberg;Thomas F. Pajak;Daniel G. Sheahan

  • Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer.

    Ronan J. Kelly;Jaffer A. Ajani;Jaroslaw Kuzdzal;Thomas Zander

  • Genomic and Functional Approaches to Understanding Cancer Aneuploidy

    Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao

  • Updated Analysis of SWOG-Directed Intergroup Study 0116: A Phase III Trial of Adjuvant Radiochemotherapy Versus Observation After Curative Gastric Cancer Resection

    Stephen R. Smalley;Jacqueline K. Benedetti;Daniel G. Haller;Scott A. Hundahl

  • Fluorouracil, Mitomycin, and Radiotherapy vs Fluorouracil, Cisplatin, and Radiotherapy for Carcinoma of the Anal Canal: A Randomized Controlled Trial

    Jaffer A. Ajani;Kathryn A. Winter;Leonard L. Gunderson;John Pedersen

  • The role of ferroptosis in ionizing radiation-induced cell death and tumor suppression.

    Guang Lei;Guang Lei;Yilei Zhang;Pranavi Koppula;Xiaoguang Liu

  • Gastric Cancer, Version 3.2016; Clinical Practice Guidelines in Oncology

    Jaffer A. Ajani;Thomas A. D'Amico;Khaldoun Almhanna;David J. Bentrem

  • Esophageal and Esophagogastric Junction Cancers, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.

    Jaffer A. Ajani;Thomas A. D'Amico;David J. Bentrem;Joseph Chao

  • Fluorouracil, Doxorubicin, and Streptozocin in the Treatment of Patients With Locally Advanced and Metastatic Pancreatic Endocrine Carcinomas

    Maria A. Kouvaraki;Jaffer A. Ajani;Paulo Hoff;Robert Wolff

  • Recommended Guidelines for the Treatment of Cancer Treatment-Induced Diarrhea

    Al B. Benson;Jaffer A. Ajani;Robert B. Catalano;Constance Engelking

  • Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroœsophageal junction

    J.S MacDonald;S.R Smalley;J Benedetti;S.A Hundhal

Frequent Co-Authors

Wayne L. Hofstetter
Wayne L. Hofstetter The University of Texas MD Anderson Cancer Center
Paul F. Mansfield
Paul F. Mansfield The University of Texas MD Anderson Cancer Center
Stephen G. Swisher
Stephen G. Swisher The University of Texas MD Anderson Cancer Center
Ritsuko Komaki
Ritsuko Komaki The University of Texas MD Anderson Cancer Center
David C. Rice
David C. Rice The University of Texas MD Anderson Cancer Center
Bruce D. Minsky
Bruce D. Minsky The University of Texas MD Anderson Cancer Center
Jack A. Roth
Jack A. Roth The University of Texas MD Anderson Cancer Center
Ara A. Vaporciyan
Ara A. Vaporciyan The University of Texas MD Anderson Cancer Center
Zhongxing Liao
Zhongxing Liao The University of Texas MD Anderson Cancer Center
Xuemei Wang
Xuemei Wang The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

As you explore the journey toward a medical career in the USA, it’s important to consider the flexible pathways available through online education. Many healthcare professionals are choosing accelerated or flexible programs to fast-track their career growth while managing work or personal commitments.

For nurses targeting advanced practice roles, several schools now offer fastest msn to dnp program options, allowing registered nurses to achieve a Doctor of Nursing Practice degree efficiently. If you are looking for accessible routes, there are also easiest dnp programs designed to support working nurses in advancing their education with less intensive admission requirements.

For those just starting out, fast track medical programs are popular choices, especially among students seeking quicker entry into nursing or allied health fields. Meanwhile, aspiring psychiatric mental health nurse practitioners can pursue specialized online msn pmhnp programs to address the growing demand in mental health care.

Exploring these online options can provide a flexible and practical route to a fulfilling medical career in the USA.

Best Scientists Citing Jaffer A. Ajani

Trending Scientists